EYENOVIA INC (EYEN) Fundamental Analysis & Valuation

NASDAQ:EYEN • US30234E2037

Current stock price

15.82 USD
+5.26 (+49.81%)
At close:
15.9 USD
+0.08 (+0.51%)
After Hours:

This EYEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EYEN Profitability Analysis

1.1 Basic Checks

  • In the past year EYEN has reported negative net income.
  • In the past year EYEN has reported a negative cash flow from operations.
  • In the past 5 years EYEN always reported negative net income.
  • EYEN had a negative operating cash flow in each of the past 5 years.
EYEN Yearly Net Income VS EBIT VS OCF VS FCFEYEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • EYEN's Return On Assets of -708.22% is on the low side compared to the rest of the industry. EYEN is outperformed by 96.91% of its industry peers.
Industry RankSector Rank
ROA -708.22%
ROE N/A
ROIC N/A
ROA(3y)-514.41%
ROA(5y)-328.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EYEN Yearly ROA, ROE, ROICEYEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EYEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EYEN Yearly Profit, Operating, Gross MarginsEYEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K -600K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EYEN Health Analysis

2.1 Basic Checks

  • EYEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EYEN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EYEN has more shares outstanding
  • Compared to 1 year ago, EYEN has a worse debt to assets ratio.
EYEN Yearly Shares OutstandingEYEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
EYEN Yearly Total Debt VS Total AssetsEYEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • EYEN has an Altman-Z score of -62.11. This is a bad value and indicates that EYEN is not financially healthy and even has some risk of bankruptcy.
  • EYEN has a Altman-Z score of -62.11. This is amonst the worse of the industry: EYEN underperforms 93.30% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -62.11
ROIC/WACCN/A
WACC10.96%
EYEN Yearly LT Debt VS Equity VS FCFEYEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

2.3 Liquidity

  • EYEN has a Current Ratio of 0.34. This is a bad value and indicates that EYEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EYEN's Current ratio of 0.34 is on the low side compared to the rest of the industry. EYEN is outperformed by 94.85% of its industry peers.
  • A Quick Ratio of 0.34 indicates that EYEN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.34, EYEN is doing worse than 93.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
EYEN Yearly Current Assets VS Current LiabilitesEYEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. EYEN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.07% over the past year.
  • The Revenue has grown by 781.58% in the past year. This is a very strong growth!
  • EYEN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -84.00% yearly.
EPS 1Y (TTM)43.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.14%
Revenue 1Y (TTM)781.58%
Revenue growth 3Y-84%
Revenue growth 5YN/A
Sales Q2Q%275%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.19% on average over the next years. This is quite good.
  • EYEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 135.99% yearly.
EPS Next Y33.51%
EPS Next 2Y21.63%
EPS Next 3Y20.36%
EPS Next 5Y15.19%
Revenue Next Year400.98%
Revenue Next 2Y356.17%
Revenue Next 3Y250.09%
Revenue Next 5Y135.99%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EYEN Yearly Revenue VS EstimatesEYEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
EYEN Yearly EPS VS EstimatesEYEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. EYEN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EYEN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EYEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EYEN Price Earnings VS Forward Price EarningsEYEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EYEN Per share dataEYEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

  • EYEN's earnings are expected to grow with 20.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.63%
EPS Next 3Y20.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EYEN Dividend Analysis

5.1 Amount

  • EYEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

EYEN Fundamentals: All Metrics, Ratios and Statistics

EYENOVIA INC

NASDAQ:EYEN (7/2/2025, 8:00:02 PM)

After market: 15.9 +0.08 (+0.51%)

15.82

+5.26 (+49.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-19
Earnings (Next)08-11
Inst Owners9.67%
Inst Owner Change92.79%
Ins Owners0.74%
Ins Owner Change0%
Market Cap80.68M
Revenue(TTM)67.00K
Net Income(TTM)-42.38M
Analysts47.5
Price Target163.2 (931.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.5%
Min EPS beat(2)5.64%
Max EPS beat(2)83.35%
EPS beat(4)3
Avg EPS beat(4)17.71%
Min EPS beat(4)-37.25%
Max EPS beat(4)83.35%
EPS beat(8)5
Avg EPS beat(8)6.62%
EPS beat(12)7
Avg EPS beat(12)7.27%
EPS beat(16)10
Avg EPS beat(16)16.18%
Revenue beat(2)0
Avg Revenue beat(2)-96.53%
Min Revenue beat(2)-96.75%
Max Revenue beat(2)-96.32%
Revenue beat(4)0
Avg Revenue beat(4)-97.36%
Min Revenue beat(4)-98.79%
Max Revenue beat(4)-96.32%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1204.21
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-34.16
EYN/A
EPS(NY)-26.52
Fwd EYN/A
FCF(TTM)-4.85
FCFYN/A
OCF(TTM)-4.84
OCFYN/A
SpS0.01
BVpS-1.9
TBVpS-1.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -708.22%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-514.41%
ROA(5y)-328.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z -62.11
F-Score3
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)219.51%
Cap/Depr(5y)330.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.14%
EPS Next Y33.51%
EPS Next 2Y21.63%
EPS Next 3Y20.36%
EPS Next 5Y15.19%
Revenue 1Y (TTM)781.58%
Revenue growth 3Y-84%
Revenue growth 5YN/A
Sales Q2Q%275%
Revenue Next Year400.98%
Revenue Next 2Y356.17%
Revenue Next 3Y250.09%
Revenue Next 5Y135.99%
EBIT growth 1Y-0.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-88.59%
EBIT Next 3Y54.61%
EBIT Next 5Y39.01%
FCF growth 1Y2.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.27%
OCF growth 3YN/A
OCF growth 5YN/A

EYENOVIA INC / EYEN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EYENOVIA INC?

ChartMill assigns a fundamental rating of 1 / 10 to EYEN.


Can you provide the valuation status for EYENOVIA INC?

ChartMill assigns a valuation rating of 1 / 10 to EYENOVIA INC (EYEN). This can be considered as Overvalued.


What is the profitability of EYEN stock?

EYENOVIA INC (EYEN) has a profitability rating of 0 / 10.


How financially healthy is EYENOVIA INC?

The financial health rating of EYENOVIA INC (EYEN) is 0 / 10.